Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof

作者: Nivedita Namdev , Kiyoshi Nakayama , Brian Schwartz , Jean-Marc Lapierre , Sudharshan Eathiraj

DOI:

关键词:

摘要: The application relates to a compound of Formula (I): or pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog derivative which modulates the activity BTK, pharmaceutical composition comprising (I), and method treating preventing disease in BTK plays role.

参考文章(73)
Marika Nespi, Wayne Spevak, Klaus-Peter Hirth, Prabha N. Ibrahim, Songyuan Shi, Betsy Burton, Gaston G. Habets, Chao Zhang, Compounds for kinase modulation, and indications therefor ,(2014)
Gideon Shapiro, Richard Chesworth, Oscar Miguel Moradei, Lei Jin, Robert E. Babine, CARM1 inhibitors and uses thereof ,(2014)
Bruno Schoentjes, Virginie Sophie Poncelet, Pierre-Henri Storck, Sophie Coupa, Inhibitors of the interaction between mdm2 and p53 ,(2008)
Serge Mignani, Jean-Christophe Carry, Heinz-Werner Kleemann, Jean Bouquerel, Pascal Desmazeau, Baptiste Ronan, Arielle Genevois-Borella, 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them ,(2003)
Paul Steven Changelian, Method of treatment of atherosclerosis ,(2004)
James Fleming, Susan L. Lindquist, Tiago Outeiro, Christine Ellen Bulawa, Richard Labaudiniere, Charlotte Weigel, Sandeep Gupta, Amy Ripka, Feng Liang, Inhibition of alpha-synuclein toxicity ,(2007)
Wade A. Russu, Hassan M. Shallal, Piperazinylpyrimidine analogues as protein kinase inhibitors ,(2011)
Todd Bosanac, Michael J Burke, Darren DiSalvo, Wang Mao, John Westbrook, Heteroaromatic compounds as btk inhibitors ,(2014)
John M. Yanni, Daniel A. Gamache, Allen J. Borchardt, Clay Beauregard, Robert L. Davis, Aminopyrimidine inhibitors of histamine receptors for the treatment of disease ,(2009)